Data Integrity, Lab Control Issues Lead to Form 483s for Two Manufacturers

Drug Industry Daily
A A
The FDA issued Form 483s to two drug manufacturers for data integrity and laboratory issues.

To View This Article:

Login

Subscribe To Drug Industry Daily